Important Clinical Syndromes Associated with Liver Disease

Veterinary Clinics of North America - Small Animal Practice

Volumn 39, Issue 3, 2009, Pages 419-437

  Rothuizen, Jan ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Ascites; Bile acids; Bilirubin; Cholestasis; Coagulopathy; Hepatic encephalopathy; Icterus; Liver disease; Portal hypertension; Portosystemic shunting

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMMONIA; BENZODIAZEPINE RECEPTOR; BILIRUBIN; GLUTAMIC ACID; LACTULOSE;

ASCITES; BILE FLOW; BILIRUBIN METABOLISM; BLOOD CLOTTING DISORDER; CATECHOLAMINERGIC SYSTEM; CHOLESTASIS; DIAGNOSTIC VALUE; DIET THERAPY; DISEASE ASSOCIATION; EXTRAHEPATIC BILE DUCT OBSTRUCTION; HEPATIC ENCEPHALOPATHY; HEPATOBILIARY DISEASE; HISTOPATHOLOGY; INTRAHEPATIC CHOLESTASIS; JAUNDICE; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PROTEIN RESTRICTION; REVIEW; VETERINARY MEDICINE;

ANIMALS; ASCITES; BILIRUBIN; BLOOD COAGULATION DISORDERS; CHOLESTASIS; COLLATERAL CIRCULATION; COMORBIDITY; HEPATIC ENCEPHALOPATHY; HYPERTENSION, PORTAL; JAUNDICE; LIVER DISEASES; SYNDROME;

EID: 67649414411     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2009.02.007     Document Type: Review

References (55)

1. Shafik A. Cholecysto-sphincter inhibitory reflex: identification of a reflex and its role in bile flow in a canine model. J Invest Surg 11 (1998) 199-205
2. Abiru H., Sarna S.K., and Condon R.E. Contractile mechanisms of gallbladder filling and emptying in dogs. Gastroenterology 106 6 (1994) 1652-1661
3. Rothuizen J., de Vries-Chalmers H., van Papendrecht R., et al. Post prandial and cholecystokinin-induced emptying of the gall bladder in dogs. Vet Rec 126 (1990) 505-507
4. Pozo M.J., Salido G.M., and Madrid J.A. Action of cholecystokinin on the dog sphincter of Oddi: influence of anti-cholinergic agents. Arch Int Physiol Biochim 98 (1990) 353-360
5. Westfall S.G., Deshpande Y.G., and Kaminski D.L. Role of glucagon and insulin in canine bile flow stimulated by endogenous cholecystokinin release. Am J Surg 157 (1989) 130-136
6. Kaminski D.L., Deshpande Y.G., and Beinfeld M.C. Role of glucagon in cholecystokinin-stimulated bile flow in dogs. Am J Physiol 254 (1988) G864-G869
7. Westfall S., Andrus C., Schlarman D., et al. The effect of cholecystokinin-receptor antagonists on cholecystokinin-stimulated bile flow in dogs. Surgery 109 (1991) 294-300
8. Mochinaga N., Sarna S.K., Condon R.E., et al. Gastroduodenal regulation of common duct bile flow in the dog. Gastroenterology 94 (1988) 755-761
9. Center S.A. Serum bile acids in companion animal medicine. Vet Clin North Am Small Anim Pract 23 3 (1993) 625-657
10. Mahmood I. Interspecies scaling of biliary excreted drugs: a comparison of several methods. J Pharm Sci 94 (2005) 883-892
11. Matsumura J., Neri K., and Rege R.V. Hypercholeresis with cholate infusion in dogs with pigment gallstones. Dig Dis Sci 41 (1996) 272-281
12. Ingh T.S., Cullen J.M., Twedt D.C., et al. Morphological classification of biliary disorders of the canine and feline liver. In: WSAVA Liver Standardization Group (Ed). WSAVA standards for clinical and histological diagnosis of canine and feline liver diseases (2006), Churchill Livingstone, Edinburgh (UK) 61-76
13. Tierney S., Nakeeb A., Wong O., et al. Progesterone alters biliary flow dynamics. Ann Surg 229 (1999) 205-209
14. van den Ingh T.S., Rothuizen J., and van Zinnicq Bergman H.M.S. Destructive cholangiolitis in seven dogs. Vet Q 10 (1988) 240-245
15. Rothuizen J., and van den Brom W.E. Quantitative hepatobiliary scintigraphy as a measure of bile flow in dogs with cholestatic disease. Am J Vet Res 51 (1990) 253-256
16. van den Ingh T.S., Rothuizen J., and van den Brom W.E. Extrahepatic cholestasis in the dog and the differentiation of extrahepatic and intrahepatic cholestasis. Vet Q 150 (1986) 150-157
17. Boothe H.W., Boothe D.M., Komkov A., et al. Use of hepatobiliary scintigraphy in the diagnosis of extrahepatic biliary obstruction in dogs and cats: 25 cases (1982-1989). J Am Vet Med Assoc 201 (1992) 134-141
18. Usui R., Ise H., Kitayama O., et al. Bilirubin conjugation and biliary bilirubin excretion after intravenous bilirubin injection in dogs. Tohoku J Exp Med 165 (1991) 67-77
19. Rothuizen J., van den Brom W.E., and Fevery J. The origins and kinetics of bilirubin in healthy dogs, in comparison with man. J Hepatol 15 (1992) 25-34
20. Rothuizen J., van den Brom W.E., and Fevery J. The origins and kinetics of bilirubin in dogs with hepatobiliary and haemolytic diseases. J Hepatol 15 (1992) 17-24
21. Rothuizen J., and van den Brom W.E. Bilirubin metabolism in canine hepatobiliary and haemolytic disease. Vet Q 9 (1987) 235-240
22. Rothuizen J., and van den Ingh T. Covalently protein-bound bilirubin conjugates in cholestatic disease of dogs. Am J Vet Res 49 (1988) 702-704
23. Cullen J.M., van den Ingh T., Bunch S.E., et al. Morphological classification of circulatory disorders of the canine and feline liver. In: WSAVA Liver Standardization Group (Ed). WSAVA standards for clinical and histological diagnosis of canine and feline liver diseases (2006), Churchill Livingstone, Edinburgh (UK) 41-59
24. Spee B., Penning L.C., van den Ingh T.S., et al. Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment. Comp Hepatol 4 (2005) 7-13
25. Zandvliet M.M., Szatmari V., van den Ingh T., et al. Acquired portosystemic shunting in 2 cats secondary to congenital hepatic fibrosis. J Vet Intern Med 19 (2005) 765-767
26. Van den Ingh T.S., and Rothuizen J. Portal hypertension associated with primary hypoplasia of the hepatic portal vein in dogs. Vet Rec 137 (1995) 424-427
27. Schermerhorn T., Center S.A., Dykes N.L., et al. Characterization of hepatoportal microvascular dysplasia in a kindred of cairn terriers. J Vet Intern Med 10 (1996) 219-230
28. Hess P.R., and Bunch S.E. Management of portal hypertension and its consequences. Vet Clin North Am Small Anim Pract 25 (1995) 461-483
29. Szatmari V., Rothuizen J., van den Ingh T.S., et al. Ultrasonographic findings in dogs with hyperammonemia: 90 cases (2000-2002). J Am Vet Med Assoc 224 (2004) 717-727
30. Szatmari V., Rothuizen J., and Voorhout G. Standard planes for ultrasonographic examination of the portal system in dogs. J Am Vet Med Assoc 224 (2004) 713-716 698-9
31. Szatmari V., and Rothuizen J. Ultrasonographic identification and characterization of congenital portosystemic shunts and portal hypertensive disorders in dogs and cats. In: WSAVA Liver Standardization Group (Ed). WSAVA standards for clinical and histological diagnosis of canine and feline liver diseases (2006), Churchill Livingstone, Edinburgh (UK) 15-40
32. Schipper L., Spee B., Rothuizen J., et al. Characterisation of 11 beta-hydroxysteroid dehydrogenases in feline kidney and liver. Biochim Biophys Acta 1688 (2004) 68-77
33. Frey F.J. Impaired 11 beta-hydroxysteroid dehydrogenase contributes to renal sodium avidity in cirrhosis: hypothesis or fact?. Hepatology 44 (2006) 795-801
34. Morris D.J., Souness G.W., Latif S.A., et al. Effect of chenodeoxycholic acid on 11beta-hydroxysteroid dehydrogenase in various target tissues. Metabolism 53 (2004) 811-816
35. Stauffer A.T., Rochat M.K., Dick B., et al. Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor. J Biol Chem 277 (2002) 26286-26292
36. Quattropani C., Vogt B., Odermatt A., et al. Reduced activity of 11beta-hydroxysteroid dehydrogenase in patients with cholestasis. J Clin Invest 108 (2001) 1299-1305
37. Ackermann D., Vogt B., Escher G., et al. Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis. Hepatology 30 (1999) 623-629
38. Gomez-Sanchez E.P., and Gomez-Sanchez C.E. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Am J Physiol 263 (1992) E1125-E1130
39. Gerritzen-Bruing M.J., van den Ingh T.S., and Rothuizen J. Diagnostic value of fasting plasma ammonia and bile acid concentrations in identification of portosystemic shunting in dogs. J Vet Intern Med 20 (2006) 13-19
40. Rothuizen J., and van den Ingh T.S. Rectal ammonia tolerance test in the evaluation of portal circulation in dogs with liver disease. Res Vet Sci 33 (1982) 22-25
41. Maddison J.E. Hepatic encephalopathy. Current concepts of the pathogenesis. J Vet Intern Med 6 (1992) 341-353
42. Butterworth R.F. Hepatic encephalopathy. In: Arias I.M. (Ed). Liver: biology and pathobiology. 3rd edition (1994), Raven Press, New York 1193-1208
43. Conn H.O., and Bircher J. Hepatic encephalopathy: management with lactulose and related carbohydrates (1988), Medi-Ed Press, East Lansing (MI)
44. Jones E.A., Schafer D.F., Ferenci P., et al. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status. Yale J Biol Med 57 (1984) 301-316
45. Ferenci P., Riederer P., Jellinger K., et al. Changes in cerebral receptors for gamma aminobutyric acid in patients with hepatic encephalopathy. Liver 8 (1988) 225-230
46. Meyer H.P., Chamuleau R.A., Legemate D.A., et al. Effects of a branched-chain amino acid-enriched diet on chronic hepatic encephalopathy in dogs. Metab Brain Dis 14 (1999) 103-115
47. Rothuizen J., Biewenga W.J., and Mol J.A. Chronic glucocorticoid excess and impaired osmoregulation of vasopressin release in dogs with hepatic encephalopathy. Domest Anim Endocrinol 12 (1995) 13-24
48. Rothuizen J., and van den Ingh T.S. Arterial and venous ammonia concentrations in the diagnosis of canine hepato-encephalopathy. Res Vet Sci 33 (1982) 17-21
49. Sterczer A., Meyer H.P., Boswijk H.C., et al. Evaluation of ammonia measurements in dogs with two analysers for use in veterinary practice. Vet Rec 144 (1999) 523-526
50. Bigge L.A., Brown D.J., and Penninck D.G. Correlation between coagulation profile findings and bleeding complications after ultrasound-guided biopsies: 434 cases (1993-1996). J Am Anim Hosp Assoc 37 (2001) 228-233
51. Léveillé R., Partington B.P., Biller D.S., et al. Complications after ultrasound-guided biopsy of abdominal structures in dogs and cats: 246 cases (1984-1991). J Am Vet Med Assoc 203 (1993) 413-415
52. Badylak S., Dodds W.J., and Van Vleet J.F. Plasma coagulation factor abnormalities in dogs with naturally occurring hepatic disease. Am J Vet Res 44 (1983) 2336-2340
53. Badylak S., and Van Vleet J.F. Alterations of prothrombin time and activated partial thromboplastin time in dogs with hepatic disease. Am J Vet Res 42 (1981) 2053-2056
54. Plourde V., Gascon-Barré M., Willems B., et al. Severe cholestasis leads to vitamin D depletion without perturbing its C-25 hydroxylation in the dog. Hepatology 8 6 (1988) 1577-1585
55. Mount M.E., Kim B.U., and Kass P.H. Use of a test for proteins induced by vitamin K absence or antagonism in diagnosis or anticoagulant poisoning in dogs. J Am Vet Med Assoc 222 (2003) 194-198